Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Pieters

Showing results (161-170 of 392) with videos related to

Pageof 40
Sort By:
Haematologica|February 14, 2013
Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infantsEmma M C Driessen, Eddy H J van Roon, Jill A P Spijkers-Hagelstein, et al.
Journal of Palliative Medicine|February 14, 2015
Parents' Faith and Hope during the Pediatric Palliative Phase and the Association with Long-Term Parental AdjustmentIvana M M van der Geest, Marry M van den Heuvel-Eibrink, Nette Falkenburg, et al.
Cancer|July 15, 2005
Pediatric aggressive fibromatosis: a retrospective analysis of 13 patients and review of literatureSaskia Buitendijk, Cees P van de Ven, Ton G Dumans, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2021
Hypersensitivity to Pegylated E.coli asparaginase as first-line treatment in contemporary paediatric acute lymphoblastic leukaemia protocols: a meta-analysis of the Ponte di Legno Toxicity working groupLeiah J Brigitha, Marta Fiocco, Rob Pieters, et al.
Haematologica|February 14, 2013
Cost-analysis of treatment of childhood acute lymphoblastic leukemia with asparaginase preparations: the impact of expensive chemotherapyWing H Tong, Inge M van der Sluis, Cathelijne J M Alleman, et al.
International Journal of Molecular Sciences|June 19, 2024
Distinct Responses to Menin Inhibition and Synergy with DOT1L Inhibition in <i>KMT2A</i>-Rearranged Acute Lymphoblastic and Myeloid LeukemiaFabienne R S Adriaanse, Pauline Schneider, Susan T C J M Arentsen-Peters, et al.
Pediatric Blood & Cancer|January 10, 2009
Pharmacokinetics of high-dose methotrexate in infants treated for acute lymphoblastic leukemiaGudmar Lönnerholm, Maria Grazia Valsecchi, Paola De Lorenzo, et al.
Frontiers in Immunology|February 7, 2017
Loss of CD44<sup>dim</sup> Expression from Early Progenitor Cells Marks T-Cell Lineage Commitment in the Human ThymusKirsten Canté-Barrett, Rui D Mendes, Yunlei Li, et al.
Journal of Cachexia, Sarcopenia and Muscle|August 10, 2023
The utility of a portable muscle ultrasound in the assessment of muscle alterations in children with acute lymphoblastic leukaemiaEmma J Verwaaijen, Annelienke M van Hulst, Jeroen Molinger, et al.
Plos One|July 10, 2018
Global methylation in relation to methotrexate-induced oral mucositis in children with acute lymphoblastic leukemiaNatanja Oosterom, Pieter H Griffioen, Marissa A H den Hoed, et al.
Pageof 40

Showing results (161-170 of 392) with videos related to

Sort By:
Pageof 40
Haematologica|February 14, 2013
Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infantsEmma M C Driessen, Eddy H J van Roon, Jill A P Spijkers-Hagelstein, et al.
Journal of Palliative Medicine|February 14, 2015
Parents' Faith and Hope during the Pediatric Palliative Phase and the Association with Long-Term Parental AdjustmentIvana M M van der Geest, Marry M van den Heuvel-Eibrink, Nette Falkenburg, et al.
Cancer|July 15, 2005
Pediatric aggressive fibromatosis: a retrospective analysis of 13 patients and review of literatureSaskia Buitendijk, Cees P van de Ven, Ton G Dumans, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2021
Hypersensitivity to Pegylated E.coli asparaginase as first-line treatment in contemporary paediatric acute lymphoblastic leukaemia protocols: a meta-analysis of the Ponte di Legno Toxicity working groupLeiah J Brigitha, Marta Fiocco, Rob Pieters, et al.
Haematologica|February 14, 2013
Cost-analysis of treatment of childhood acute lymphoblastic leukemia with asparaginase preparations: the impact of expensive chemotherapyWing H Tong, Inge M van der Sluis, Cathelijne J M Alleman, et al.
International Journal of Molecular Sciences|June 19, 2024
Distinct Responses to Menin Inhibition and Synergy with DOT1L Inhibition in <i>KMT2A</i>-Rearranged Acute Lymphoblastic and Myeloid LeukemiaFabienne R S Adriaanse, Pauline Schneider, Susan T C J M Arentsen-Peters, et al.
Pediatric Blood & Cancer|January 10, 2009
Pharmacokinetics of high-dose methotrexate in infants treated for acute lymphoblastic leukemiaGudmar Lönnerholm, Maria Grazia Valsecchi, Paola De Lorenzo, et al.
Frontiers in Immunology|February 7, 2017
Loss of CD44<sup>dim</sup> Expression from Early Progenitor Cells Marks T-Cell Lineage Commitment in the Human ThymusKirsten Canté-Barrett, Rui D Mendes, Yunlei Li, et al.
Journal of Cachexia, Sarcopenia and Muscle|August 10, 2023
The utility of a portable muscle ultrasound in the assessment of muscle alterations in children with acute lymphoblastic leukaemiaEmma J Verwaaijen, Annelienke M van Hulst, Jeroen Molinger, et al.
Plos One|July 10, 2018
Global methylation in relation to methotrexate-induced oral mucositis in children with acute lymphoblastic leukemiaNatanja Oosterom, Pieter H Griffioen, Marissa A H den Hoed, et al.
Pageof 40